From Spice to Scaffold: Design and Development of Curcumin Analogs to Combat Pancreatic Cancer

References (72)

1. 1 Park, 2021, Pancreatic cancer: A review [DOI]
2. 2 (2026, May 22). World Cancer Research Fund. Available online: https://www.wcrf.org/preventing-cancer/cancer-statistics/pancreatic-cancer-statistics/.
3. 3 American Cancer Society (2026). Cancer Facts & Figures 2026, American Cancer Society.
4. 4 Wang, 2024, The relationship and clinical significance of lactylation modification in digestive system tumors [DOI]
5. 5 Simoes, 2017, Epidemiology of pancreatic adenocarcinoma [DOI]
6. 6 Mannucci, 2026, Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
7. 7 Zhang, 2018, Novel agents for pancreatic ductal adenocarcinoma: Emerging therapeutics and future directions [DOI]
8. 8 Aggarwal, 2009, Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets [DOI]
9. 9 Jha, 2017, Curcumin: Not So Spicy after All [DOI]
10. 10 Jha, 2006, 3,5-Bis(arylmethylene)-4-piperidone Derivatives as Novel Anticancer Agents
11. 11 Gupta, 2013, Therapeutic roles of curcumin: Lessons learned from clinical trials [DOI]
12. 12 Kunnumakkara, 2008, Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins [DOI]
13. 13 Kuo, 1996, Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells [DOI]
14. 14 Chen, 1999, Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells
15. 15 Mehta, 1997, Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines [DOI]
16. 16 Lu, 1994, Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-jun and c-fos in JB6 cells and in mouse epidermis [DOI]
17. 17 Limtrakul, 1997, Inhibitory effect of dietary curcumin on skin carcinogenesis in mice [DOI]
18. 18 Huang, 1997, Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis [DOI]
19. 19 Huang, 1991, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis
20. 20 Huang, 1994, Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice
21. 21 Huang, 1998, Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in sencar mice [DOI]
22. 22 Kim, 1998, Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation [DOI]
23. 23 Rao, 1995, Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound
24. 24 Kawamori, 1999, Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer
25. 25 Chuang, 2000, Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis [DOI]
26. 26 Li, 2004, Nuclear factor-κB and IκB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis [DOI]
27. 27 Dhillon, 2008, Phase II trial of curcumin in patients with advanced pancreatic cancer [DOI]
28. 28 Cao, J., Hang, K., Zhang, H., Xia, Q., Zhang, X., Men, J., Tian, J., Xia, Z., Liao, D., and Li, K. (2025). Mechanistic insights curcumin’s anti-inflammatory in pancreatic cancer: Experimental and computational evidence implicating IL1B interference via IL10RA upregulation and NLRP3/TLR3 downregulation. Front. Cell Dev. Biol., 13. [DOI]
29. 29 Cao, 2025, Insights into curcumin’s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1 [DOI]
30. 30 Zang, 2014, Curcumin: A promising agent targeting cancer stem cells [DOI]
31. 31 Li, 2014, Targeting cancer stem cells by curcumin and clinical applications [DOI]
32. 32 Subramaniam, 2018, Targeting cancer stem cells for chemoprevention of pancreatic cancer [DOI]
33. 33 Anand, 2007, Bioavailability of curcumin: Problems and promises [DOI]
34. 34 Mardaneh, 2025, Synthetic curcumin analogs in the treatment of cancer: A literature review [DOI]
35. 35 Martins, 2023, Curcumin in inflammatory bowel diseases: Cellular targets and molecular mechanisms [DOI]
36. 36 Robinson, 2003, Design, synthesis, and biological evaluation of angiogenesis inhibitors: Aromatic enone and dienone analogues of curcumin [DOI]
37. 37 Adams, 2004, Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents [DOI]
38. 38 Ohori, 2006, Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer [DOI]
39. 39 Subramaniam, 2008, Diphenyl difluoroketone: A curcumin derivative with potent in vivo anticancer activity [DOI]
40. 40 Friedman, 2009, Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells [DOI]
41. 41 Lin, 2010, Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells [DOI]
42. 42 Padhye, 2009, New difluoro knoevenagel condensates of curcumin, their schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells [DOI]
43. 43 Padhye, 2009, Fluorocurcumins as cyclooxygenase-2 inhibitor: Molecular docking, pharmacokinetics and tissue distribution in mice [DOI]
44. 44 Bao, 2012, Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression [DOI]
45. 45 Soubani, 2012, Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer [DOI]
46. 46 Dandawate, 2012, Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer [DOI]
47. 47 Kesharwani, 2015, Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer [DOI]
48. 48 Bhattacharyya, S., Ghosh, H., Covarrubias-Zambrano, O., Jain, K., Swamy, K.V., Kasi, A., Hamza, A., Anant, S., VanSaun, M., and Weir, S.J. (2023). Anticancer activity of novel difluorinated curcumin analog and its inclusion complex with 2-hydroxypropyl-β-cyclodextrin against pancreatic cancer. Int. J. Mol. Sci., 24. [DOI]
49. 49 Sato, 2011, Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis [DOI]
50. 50 Wei, 2012, Synthesis and evaluation of curcumin-related compounds for anticancer activity [DOI]
51. 51 Wu, 2020, (3E,5E)-3,5-bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells [DOI]
52. 52 Lagisetty, 2012, Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH) [DOI]
53. 53 Bisht, 2016, A liposomal formulation of the synthetic curcumin analog EF24 (lipo-EF24) inhibits pancreatic cancer progression: Towards future combination therapies [DOI]
54. 54 Nagaraju, 2013, Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer [DOI]
55. 55 Nagaraju, 2015, Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer [DOI]
56. 56 Gundewar, 2015, Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: A comparative study
57. 57 Solano, 2015, Synthesis, in vitro, and in vivo evaluation of novel functionalized quaternary ammonium curcuminoids as potential anti-cancer agents [DOI]
58. 58 Xie, 2017, Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer [DOI]
59. 59 Kasinski, 2008, Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin [DOI]
60. 60 Olivera, 2012, Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties [DOI]
61. 61 Selvendiran, 2010, Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts [DOI]
62. 62 Hu, 2017, A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells [DOI]
63. 63 Mast, 2019, Diarylidenylpiperidones, H-4073 and HO-3867, induce G2/M cell-cycle arrest, apoptosis and inhibit STAT3 phosphorylation in human pancreatic cancer cells [DOI]
64. 64 Revalde, 2017, Curcumin and its cyclohexanone analogue inhibited human equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells [DOI]
65. 65 Szebeni, G.J., Balázs, Á., Madarász, I., Pócz, G., Ayaydin, F., Kanizsai, I., Fajka-Boja, R., Alföldi, R., Hackler, L., and Puskás, L.G. (2017). Achiral mannich-base curcumin analogs induce unfolded protein response and mitochondrial membrane depolarization in PANC-1 cells. Int. J. Mol. Sci., 18. [DOI]
66. 66 Li, 2019, KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma [DOI]
67. 67 Chen, H., Jiang, Y., Liu, R., Deng, J., Chen, Q., Chen, L., Liang, G., Chen, X., and Xu, Z. (2022). Curcumin derivative C66 suppresses pancreatic cancer progression through the inhibition of JNK-mediated inflammation. Molecules, 27. [DOI]
68. 68 Ghosh, H., Bhattacharyya, S., Schobert, R., Dandawate, P., and Biersack, B. (2023). Fluorinated and N-acryloyl-modified 3,5-di[(E)-benzylidene]piperidin-4-one curcuminoids for the treatment of pancreatic carcinoma. Pharmaceutics, 15. [DOI]
69. 69 Aggarwal, 2011, DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo [DOI]
70. 70 Jalde, 2018, Synthesis of novel chlorin e6-curcumin conjugates as photosensitizers for photodynamic therapy against pancreatic carcinoma [DOI]
71. 71 Thapa Magar, T.B., Lee, J., Lee, J.H., Jeon, J., Gurung, P., Lim, J., and Kim, Y. (2023). Novel chlorin e6-curcumin derivatives as a potential photosensitizer: Synthesis, characterization, and anticancer activity. Pharmaceutics, 15. [DOI]
72. 72 Roy, 2025, Unraveling mechanism and enhancing selectivity of a Ru(II)-bis-bipyridyl-morphocumin complex with RAFT-generated glycopolymer exploiting Warburg effect in cancer [DOI]

Cited by 0

No indexed citations yet.

Related research

• Reasons Why Students Study Medicine: Views of Students at Delta State University Abraka, South-South Nigeria — shares topic coverage
• Harnessing Artificial Intelligence in Healthcare Analytics: From Diagnosis to Treatment Optimization — shares topic coverage
• Exploring Hemophilic Pseudotumors: A Comprehensive Case Series — shares topic coverage
• A Novel Catalytic Synthesis of Flavones under Autoclave Conditions and Comparative Study of Anti-cancer Activity — shares topic coverage
• HPTLC Densitogram Profile of Aqueous Distillate (Arka) from Roots of Boerhaavia diffusa — shares topic coverage